Pheton Holdings PE Ratio 2025-2024 | PTHL

Current and historical p/e ratio for Pheton Holdings (PTHL) from 2025 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pheton Holdings PE ratio as of May 02, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Pheton Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-02 4.07 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.027B $0.000B
Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) US $142.454B 26.72
Elevance Health (ELV) US $92.629B 11.95
CVS Health (CVS) US $85.338B 10.61
Cencora (COR) US $56.647B 20.56
Natera (NTRA) US $21.178B 0.00
DiDi Global (DIDIY) CN $19.767B 30.00
BioMerieux (BMXMF) FR $15.407B 0.00
EUROFINS SCIENT (ERFSF) LU $12.351B 0.00
Solventum (SOLV) US $11.698B 10.91
CochLear (CHEOY) AU $11.662B 0.00
ICON (ICLR) IE $11.545B 10.73
Revvity (RVTY) US $11.293B 19.07
Doximity (DOCS) US $11.076B 57.60
Viatris (VTRS) US $10.258B 3.26
Avantor (AVTR) US $8.770B 12.74
Medpace Holdings (MEDP) US $8.769B 23.29
Sonic Healthcare (SKHHY) AU $8.097B 0.00
HealthEquity (HQY) US $7.835B 38.54
Charles River Laboratories (CRL) US $5.818B 11.48
Amplifon S.p.A (AMFPF) IT $4.285B 22.62
Bausch + Lomb (BLCO) CA $4.064B 23.96
BrightSpring Health Services (BTSG) US $3.654B 33.66
Sotera Health (SHC) US $3.514B 19.97
Alignment Healthcare (ALHC) US $3.073B 0.00
Surgery Partners (SGRY) US $2.959B 33.94
Concentras Parent (CON) US $2.792B 14.52
Organon (OGN) US $2.493B 2.65
Progyny (PGNY) US $1.990B 43.83
GeneDx Holdings (WGS) US $1.887B 73.88
Ardent Health Partners (ARDT) US $1.880B 0.00
Premier (PINC) US $1.868B 11.97
GoodRx Holdings (GDRX) US $1.795B 39.00
Agilon Health (AGL) US $1.718B 0.00
PACS (PACS) US $1.535B 0.00
Teladoc Health (TDOC) US $1.239B 0.00
Pediatrix Medical (MD) US $1.110B 9.31
Ryman Healthcare (RYHTY) NZ $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.963B 0.00
CareDx (CDNA) US $0.835B 13.04
AMN Healthcare Services Inc (AMN) US $0.811B 6.42
Embecta (EMBC) US $0.740B 5.07
Nutex Health (NUTX) US $0.634B 12.42
QDM (QDMI) HK $0.583B 0.00
Auna S.A (AUNA) LU $0.512B 13.57
Sonida Senior Living (SNDA) US $0.454B 0.00
InnovAge Holding (INNV) US $0.426B 0.00
Enhabit (EHAB) US $0.408B 38.33
COMPASS Pathways (CMPS) GB $0.389B 0.00
SBC Medicals (SBC) US $0.321B 0.00
LifeMD (LFMD) US $0.319B 0.00
DocGo (DCGO) US $0.236B 9.62
Oncology Institute (TOI) US $0.212B 0.00
Performant Healthcare (PHLT) US $0.196B 0.00
Beauty Health (SKIN) US $0.143B 0.00
Sera Prognostics (SERA) US $0.110B 0.00
Ascend Wellness Holdings (AAWH) US $0.090B 0.00
OncoCyte (OCX) US $0.087B 0.00
So-Young (SY) CN $0.085B 0.00
Basel Medical Group (BMGL) SG $0.077B 0.00
Biodesix (BDSX) US $0.076B 0.00
IceCure Medical (ICCM) IL $0.065B 0.00
NeueHealth (NEUE) US $0.060B 0.00
NeuroOne Medical Technologies (NMTC) US $0.030B 0.00
ModivCare (MODV) US $0.021B 7.30
KindlyMD (KDLY) US $0.013B 0.00
SeaStar Medical Holding (ICU) US $0.013B 0.00
Co-Diagnostics (CODX) US $0.012B 0.00
Intelligent Bio Solutions (INBS) US $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) US $0.004B 0.00
Aclarion (ACON) US $0.004B 0.00
ISpecimen (ISPC) US $0.003B 0.00
NewGenIvf Group (NIVF) TH $0.002B 0.00
Cano Health (CANOQ) US $0.000B 0.00